Escolar Documentos
Profissional Documentos
Cultura Documentos
http://www.micromedexsolutions.com/micromedex2/librarian/ND_T/evidencex
pert/ND_PR/evidencexpert/CS/6EA7FE/ND_AppProduct/evidencexpert/DUPL
ICATIONSHIELDSYNC/FFA249/ND_PG/evidencexpert/ND_B/evidencexpert
/ND_P/evidencexpert/PFActionId/evidencexpert.DoIntegratedSearch?
SearchTerm=metformin&UserSearchTerm=metformin&SearchFilter=filterNone
&navitem=searchALL#
Glybenclamide(Glyburide)
Type 2 diabetes mellitus: initial, 2.5 to 5 mg ORALLY once daily;
titrate in increments of no more than 2.5 mg weekly based on
glycemic response; MAX 5 mg/day; may consider initiating at 1.25
mg ORALLY once daily in patients more sensitive to hypoglycemic
drugs
http://www.micromedexsolutions.com/micromedex2/librarian/ND_T/evidencexper
t/ND_PR/evidencexpert/CS/E2793F/ND_AppProduct/evidencexpert/DUPLICATIONS
HIELDSYNC/30E97E/ND_PG/evidencexpert/ND_B/evidencexpert/ND_P/evidencexp
ert/PFActionId/evidencexpert.DoIntegratedSearch?SearchTerm=glibenclamide#
Glipizide
Type 2 diabetes mellitus: immediate-release: initial, 5 mg ORALLY
once daily
Type 2 diabetes mellitus: immediate-release: maintenance, titrate in
2.5- to 5-mg increments; allow several days between titration steps;
MAX 40 mg daily (doses above 15 mg should be divided)
http://www.micromedexsolutions.com/micromedex2/librarian/ND_T/evidencex
pert/ND_PR/evidencexpert/CS/EEEAFB/ND_AppProduct/evidencexpert/DUPL
ICATIONSHIELDSYNC/7826AA/ND_PG/evidencexpert/ND_B/evidencexper
t/ND_P/evidencexpert/PFActionId/evidencexpert.DoIntegratedSearch?
SearchTerm=Glipizide&UserSearchTerm=Glipizide&SearchFilter=filterNone&
navitem=searchGlobal#
Gliclazide
Type 2 diabetes mellitus
MAXIMUM DOSE
http://www.micromedexsolutions.com/micromedex2/librarian/ND_T/evidencex
pert/ND_PR/evidencexpert/CS/4AE311/ND_AppProduct/evidencexpert/DUPL
ICATIONSHIELDSYNC/487903/ND_PG/evidencexpert/ND_B/evidencexpert/
ND_P/evidencexpert/PFActionId/evidencexpert.DoIntegratedSearch?
SearchTerm=Gliclazide&UserSearchTerm=Gliclazide&SearchFilter=filterNone
&navitem=searchGlobal#
rd
Glimepiride
Type 2 diabetes mellitus: initial, 1 to 2 mg ORALLY once daily
http://www.micromedexsolutions.com/micromedex2/librarian/ND_T/evidencex
pert/ND_PR/evidencexpert/CS/8CAE87/ND_AppProduct/evidencexpert/DUPL
ICATIONSHIELDSYNC/910A44/ND_PG/evidencexpert/ND_B/evidencexpert
/ND_P/evidencexpert/PFActionId/evidencexpert.DoIntegratedSearch?
SearchTerm=Glimepiride&UserSearchTerm=Glimepiride&SearchFilter=filterN
one&navitem=searchGlobal#
Pioglitazone
Type 2 diabetes mellitus: initial, 15 or 30 mg ORALLY once daily;
titrate in 15-mg increments; MAX 45 mg daily
http://www.micromedexsolutions.com/micromedex2/librarian/ND_T/evidencex
pert/ND_PR/evidencexpert/CS/226B26/ND_AppProduct/evidencexpert/DUPLI
CATIONSHIELDSYNC/0B7752/ND_PG/evidencexpert/ND_B/evidencexpert/
ND_P/evidencexpert/PFActionId/evidencexpert.DoIntegratedSearch?
SearchTerm=Pioglitazone&UserSearchTerm=Pioglitazone&SearchFilter=filter
None&navitem=searchGlobal#
Acarbose
Type 2 diabetes mellitus: initial, 25 mg ORALLY 3 times a day with
the first bite of each main meal; may initiate at 25 mg ORALLY once
daily with gradual dose titration to 25 mg ORALLY 3 times a day in
some patients to minimize gastrointestinal side effects
Type 2 diabetes mellitus: maintenance, dose may be increased at 4- to
8-week intervals to 50 to 100 mg ORALLY 3 times a day with the
first bite of each main meal; MAX 50 mg three times daily for
patients weighing 60 kg or less and MAX 100 mg three times daily
for those weighing more than 60 kg
http://www.micromedexsolutions.com/micromedex2/librarian/ND_T/evidencex
pert/ND_PR/evidencexpert/CS/E46168/ND_AppProduct/evidencexpert/DUPLI
CATIONSHIELDSYNC/697E57/ND_PG/evidencexpert/ND_B/evidencexpert/
ND_P/evidencexpert/PFActionId/evidencexpert.DoIntegratedSearch?
SearchTerm=acarbose&UserSearchTerm=acarbose&SearchFilter=filterNone&n
avitem=searchGlobal#
Sitagliptin
Type 2 diabetes mellitus: 100 mg ORALLY once daily with or
without food; when administered with a sulfonylurea or insulin, a
lower dose of sulfonylurea or insulin may be required
http://www.micromedexsolutions.com/micromedex2/librarian/ND_T/eviden
cexpert/ND_PR/evidencexpert/CS/0E4285/ND_AppProduct/evidencexpert/
DUPLICATIONSHIELDSYNC/8C6D27/ND_PG/evidencexpert/ND_B/evi
dencexpert/ND_P/evidencexpert/PFActionId/evidencexpert.DoIntegratedSea
rch?
SearchTerm=Sitagliptin&UserSearchTerm=Sitagliptin&SearchFilter=filterN
one&navitem=searchGlobal#